These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 37984591)
1. Development of a monoclonal antibody specific for a calpain-generated ∆48 kDa calcineurin fragment, a marker of distressed astrocytes. Kraner SD; Sompol P; Prateeptrang S; Promkan M; Hongthong S; Thongsopha N; Nelson PT; Norris CM J Neurosci Methods; 2024 Feb; 402():110012. PubMed ID: 37984591 [TBL] [Abstract][Full Text] [Related]
2. Calpain-Mediated Alterations in Astrocytes Before and During Amyloid Chaos in Alzheimer's Disease. Schultz B; Taday J; Menezes L; Cigerce A; Leite MC; Gonçalves CA J Alzheimers Dis; 2021; 84(4):1415-1430. PubMed ID: 34719501 [TBL] [Abstract][Full Text] [Related]
4. Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture. Mohmmad Abdul H; Baig I; Levine H; Guttmann RP; Norris CM Aging Cell; 2011 Feb; 10(1):103-13. PubMed ID: 20969723 [TBL] [Abstract][Full Text] [Related]
5. Calcineurin proteolysis in astrocytes: Implications for impaired synaptic function. Pleiss MM; Sompol P; Kraner SD; Abdul HM; Furman JL; Guttmann RP; Wilcock DM; Nelson PT; Norris CM Biochim Biophys Acta; 2016 Sep; 1862(9):1521-32. PubMed ID: 27212416 [TBL] [Abstract][Full Text] [Related]
6. In vitro proteolytic degradation of bovine brain calcineurin by m-calpain. Lakshmikuttyamma A; Selvakumar P; Sharma AR; Anderson DH; Sharma RK Neurochem Res; 2004 Oct; 29(10):1913-21. PubMed ID: 15532547 [TBL] [Abstract][Full Text] [Related]
7. Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. Liu F; Grundke-Iqbal I; Iqbal K; Oda Y; Tomizawa K; Gong CX J Biol Chem; 2005 Nov; 280(45):37755-62. PubMed ID: 16150694 [TBL] [Abstract][Full Text] [Related]
8. Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. Norris CM; Kadish I; Blalock EM; Chen KC; Thibault V; Porter NM; Landfield PW; Kraner SD J Neurosci; 2005 May; 25(18):4649-58. PubMed ID: 15872113 [TBL] [Abstract][Full Text] [Related]
9. Calpain-dependent cleavage of cain/cabin1 activates calcineurin to mediate calcium-triggered cell death. Kim MJ; Jo DG; Hong GS; Kim BJ; Lai M; Cho DH; Kim KW; Bandyopadhyay A; Hong YM; Kim DH; Cho C; Liu JO; Snyder SH; Jung YK Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9870-5. PubMed ID: 12114545 [TBL] [Abstract][Full Text] [Related]
10. Blockade of Astrocytic Calcineurin/NFAT Signaling Helps to Normalize Hippocampal Synaptic Function and Plasticity in a Rat Model of Traumatic Brain Injury. Furman JL; Sompol P; Kraner SD; Pleiss MM; Putman EJ; Dunkerson J; Mohmmad Abdul H; Roberts KN; Scheff SW; Norris CM J Neurosci; 2016 Feb; 36(5):1502-15. PubMed ID: 26843634 [TBL] [Abstract][Full Text] [Related]
11. Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase. Becker B; Nazir FH; Brinkmalm G; Camporesi E; Kvartsberg H; Portelius E; Boström M; Kalm M; Höglund K; Olsson M; Zetterberg H; Blennow K Mol Neurodegener; 2018 Aug; 13(1):47. PubMed ID: 30157938 [TBL] [Abstract][Full Text] [Related]
12. Proteolytic processing of beta-amyloid precursor by calpain I. Siman R; Card JP; Davis LG J Neurosci; 1990 Jul; 10(7):2400-11. PubMed ID: 2115911 [TBL] [Abstract][Full Text] [Related]
13. Proteolysis by endogenous calpain I leads to the activation of calcineurin in human heart. Wang JC; Zhao Y; Li XD; Zhou NN; Sun H; Sun YY Clin Lab; 2012; 58(11-12):1145-52. PubMed ID: 23289183 [TBL] [Abstract][Full Text] [Related]
14. Ca Sompol P; Norris CM Front Aging Neurosci; 2018; 10():199. PubMed ID: 30038565 [TBL] [Abstract][Full Text] [Related]
15. Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. Abdul HM; Sama MA; Furman JL; Mathis DM; Beckett TL; Weidner AM; Patel ES; Baig I; Murphy MP; LeVine H; Kraner SD; Norris CM J Neurosci; 2009 Oct; 29(41):12957-69. PubMed ID: 19828810 [TBL] [Abstract][Full Text] [Related]
16. Calcium dysregulation in relation to Alzheimer-type pathology in the ageing brain. Garwood C; Faizullabhoy A; Wharton SB; Ince PG; Heath PR; Shaw PJ; Baxter L; Gelsthorpe C; Forster G; Matthews FE; Brayne C; Simpson JE; Neuropathol Appl Neurobiol; 2013 Dec; 39(7):788-99. PubMed ID: 23421725 [TBL] [Abstract][Full Text] [Related]
17. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease. Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the fragmented forms of calcineurin produced by calpain I. Wang KK; Roufogalis BD; Villalobo A Biochem Cell Biol; 1989 Oct; 67(10):703-11. PubMed ID: 2556162 [TBL] [Abstract][Full Text] [Related]
19. Astrocyte Activation and the Calcineurin/NFAT Pathway in Cerebrovascular Disease. Kraner SD; Norris CM Front Aging Neurosci; 2018; 10():287. PubMed ID: 30297999 [TBL] [Abstract][Full Text] [Related]
20. Analysis of presenilin 1 and presenilin 2 expression and processing by newly developed monoclonal antibodies. Diehlmann A; Ida N; Weggen S; Grünberg J; Haass C; Masters CL; Bayer TA; Beyreuther K J Neurosci Res; 1999 May; 56(4):405-19. PubMed ID: 10340748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]